EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis

Jiajie Kuai, Zhuo Chen, Ju He, Fengling Wang, Wei Wei

Journal of Pharmaceutical Analysis · 2026-03 · 16 (3) · 101382

DOI: 10.1016/j.jpha.2025.101382 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Pharmaceutical Analysis, 2026-03. Verfasst von Jiajie Kuai und 4 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine (Anhui Medical University), Min…. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 139 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The pleiotropic regulatory effect of tumor necrosis factor-alpha (TNF-α), an essential cytokine involved in immune regulation, is of significant importance in the immune response. TNF-α inhibitors have been widely used in rheumatoid arthritis (RA) and other autoimmune diseases since their introduction into clinical practice. However, the tradeoff between its excellent efficacy and adverse drug reactions (ADR) remains a problem. T cells, especially the T helper cell 17 (Th17)/regulatory T (Treg) cells balance, are crucial for the treatment of autoimmune diseases including RA. This review explores the mechanisms by which TNF-α/TNF receptor (TNFR) signaling induces Th17/Treg imbalance in RA. This review synthesizes current knowledge to facilitate an improved understanding of the causes of ADR, such as infection caused by TNF-α inhibitors in clinical practice. Moreover, our findings offer a reference for exploring potential TNF-α/TNFR signaling inhibitory strategies from the perspective of regulating T cell balance.

Schlagwörter

Stichwörter der Autor:innen

Rheumatoid arthritisTNF-αTNF-α inhibitorsTNFRTh17Treg

Autor:innen und Institutionen

  • Institute of Clinical Pharmacology, Anhui Medical University, Key Laboratory of Anti-Inflammatory and Immune Medicine (Anhui Medical University), Ministry of Education, Anhui Collaborative Innovation Center of Anti-infl…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Kuai, J., Chen, Z., He, J., Wang, F., & Wei, W. (2026). Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. Journal of Pharmaceutical Analysis, 16(3), 101382. https://doi.org/10.1016/j.jpha.2025.101382

Vancouver

Kuai J, Chen Z, He J, Wang F, Wei W. Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis. Journal of Pharmaceutical Analysis. 2026;16(3):101382. doi:10.1016/j.jpha.2025.101382

BibTeX
@article{Kuai2026,
  author = {Kuai, Jiajie and Chen, Zhuo and He, Ju and Wang, Fengling and Wei, Wei},
  title = {Promising TNF-α inhibitors: Targeting pathogenic TNF-α/TNFR signaling to restore Th17/Treg balance in rheumatoid arthritis},
  journal = {Journal of Pharmaceutical Analysis},
  year = {2026},
  volume = {16},
  number = {3},
  pages = {101382},
  doi = {10.1016/j.jpha.2025.101382}
}
Kostenlos starten →